Summary

The global Anti-CD45 Antibody market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Anti-CD45 Antibody is an antibody used in immunoassays that specifically binds to the CD45 protein found on the surface of leukocytes, such as lymphocytes and monocytes. CD45 is a cell surface receptor that plays a crucial role in leukocyte activation and migration. Anti-CD45 Antibody can be used in research, diagnosis, and treatment of diseases where leukocytes play a role, such as autoimmune disorders, infections, and cancer.
The industry trend for Anti-CD45 Antibody is growing due to the increasing demand for targeted immunotherapies and personalized medicine. With the development of new technologies such as immune checkpoint inhibitors and chimeric antigen receptors, Anti-CD45 Antibody is becoming more important in the treatment of various diseases. Additionally, the increasing understanding of the role of leukocytes in diseases has led to a growing interest in Anti-CD45 Antibody for research and diagnosis. However, the market for Anti-CD45 Antibody is highly competitive and companies must invest in research and development to stay ahead in the market.
The global Anti-CD45 Antibody market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
BosterBio
Novus Biologicals
Bio-Rad
MyBioSource
Leica Biosystems
Biorbyt
Thermo Fisher Scientific
R&D Systems
GeneTex
NSJ Bioreagents
Abcam
Bioss
CUSABIO Technology
LSBio
StressMarq Biosciences
BioLegend
Cell Signaling Technology
HUABIO
RayBiotech
Elabscience Bionovation
G Biosciences
Miltenyi Biotec
Beijing Solarbio Science & Technology
OriGene Technologies
American Research Products
SouthernBiotech
Tonbo Biosciences
Absolute Antibody
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Anti-CD45 Antibody market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Anti-CD45 Antibody value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-CD45 Antibody Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Anti-CD45 Antibody Market Share by Revenue, by Region (2021-2026)
2.4 Global Anti-CD45 Antibody Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Anti-CD45 Antibody Market Size and Prospective (2021-2032)
2.5.2 Europe Anti-CD45 Antibody Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Anti-CD45 Antibody Market Size and Prospective (2021-2032)
2.5.4 Latin America Anti-CD45 Antibody Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Anti-CD45 Antibody Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Anti-CD45 Antibody Historical Market Size by Type (2021-2026)
3.2 Global Anti-CD45 Antibody Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Anti-CD45 Antibody
4 Breakdown Data by Application
4.1 Global Anti-CD45 Antibody Historical Market Size by Application (2021-2026)
4.2 Global Anti-CD45 Antibody Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Anti-CD45 Antibody Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Anti-CD45 Antibody Players by Revenue (2021-2026)
5.1.2 Global Anti-CD45 Antibody Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Anti-CD45 Antibody Revenue
5.4 Global Anti-CD45 Antibody Market Concentration Analysis
5.4.1 Global Anti-CD45 Antibody Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Anti-CD45 Antibody Revenue in 2025
5.5 Global Key Players of Anti-CD45 Antibody Head Offices and Areas Served
5.6 Global Key Players of Anti-CD45 Antibody, Product and Application
5.7 Global Key Players of Anti-CD45 Antibody, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Anti-CD45 Antibody Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Anti-CD45 Antibody Market Size by Type (2021-2026)
6.1.2.2 North America Anti-CD45 Antibody Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Anti-CD45 Antibody Market Size by Application (2021-2026)
6.1.3.2 North America Anti-CD45 Antibody Market Share by Application (2021-2026)
6.1.4 North America Anti-CD45 Antibody Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Anti-CD45 Antibody Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Anti-CD45 Antibody Market Size by Type (2021-2026)
6.2.2.2 Europe Anti-CD45 Antibody Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Anti-CD45 Antibody Market Size by Application (2021-2026)
6.2.3.2 Europe Anti-CD45 Antibody Market Share by Application (2021-2026)
6.2.4 Europe Anti-CD45 Antibody Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Anti-CD45 Antibody Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Anti-CD45 Antibody Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Anti-CD45 Antibody Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Anti-CD45 Antibody Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Anti-CD45 Antibody Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Anti-CD45 Antibody Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Anti-CD45 Antibody Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Anti-CD45 Antibody Market Size by Type (2021-2026)
6.4.2.2 Latin America Anti-CD45 Antibody Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Anti-CD45 Antibody Market Size by Application (2021-2026)
6.4.3.2 Latin America Anti-CD45 Antibody Market Share by Application (2021-2026)
6.4.4 Latin America Anti-CD45 Antibody Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Anti-CD45 Antibody Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Anti-CD45 Antibody Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Anti-CD45 Antibody Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Anti-CD45 Antibody Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Anti-CD45 Antibody Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Anti-CD45 Antibody Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 BosterBio
7.1.1 BosterBio Company Details
7.1.2 BosterBio Business Overview
7.1.3 BosterBio Anti-CD45 Antibody Introduction
7.1.4 BosterBio Revenue in Anti-CD45 Antibody Business (2021-2026)
7.1.5 BosterBio Recent Development
7.2 Novus Biologicals
7.2.1 Novus Biologicals Company Details
7.2.2 Novus Biologicals Business Overview
7.2.3 Novus Biologicals Anti-CD45 Antibody Introduction
7.2.4 Novus Biologicals Revenue in Anti-CD45 Antibody Business (2021-2026)
7.2.5 Novus Biologicals Recent Development
7.3 Bio-Rad
7.3.1 Bio-Rad Company Details
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Anti-CD45 Antibody Introduction
7.3.4 Bio-Rad Revenue in Anti-CD45 Antibody Business (2021-2026)
7.3.5 Bio-Rad Recent Development
7.4 MyBioSource
7.4.1 MyBioSource Company Details
7.4.2 MyBioSource Business Overview
7.4.3 MyBioSource Anti-CD45 Antibody Introduction
7.4.4 MyBioSource Revenue in Anti-CD45 Antibody Business (2021-2026)
7.4.5 MyBioSource Recent Development
7.5 Leica Biosystems
7.5.1 Leica Biosystems Company Details
7.5.2 Leica Biosystems Business Overview
7.5.3 Leica Biosystems Anti-CD45 Antibody Introduction
7.5.4 Leica Biosystems Revenue in Anti-CD45 Antibody Business (2021-2026)
7.5.5 Leica Biosystems Recent Development
7.6 Biorbyt
7.6.1 Biorbyt Company Details
7.6.2 Biorbyt Business Overview
7.6.3 Biorbyt Anti-CD45 Antibody Introduction
7.6.4 Biorbyt Revenue in Anti-CD45 Antibody Business (2021-2026)
7.6.5 Biorbyt Recent Development
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Details
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Anti-CD45 Antibody Introduction
7.7.4 Thermo Fisher Scientific Revenue in Anti-CD45 Antibody Business (2021-2026)
7.7.5 Thermo Fisher Scientific Recent Development
7.8 R&D Systems
7.8.1 R&D Systems Company Details
7.8.2 R&D Systems Business Overview
7.8.3 R&D Systems Anti-CD45 Antibody Introduction
7.8.4 R&D Systems Revenue in Anti-CD45 Antibody Business (2021-2026)
7.8.5 R&D Systems Recent Development
7.9 GeneTex
7.9.1 GeneTex Company Details
7.9.2 GeneTex Business Overview
7.9.3 GeneTex Anti-CD45 Antibody Introduction
7.9.4 GeneTex Revenue in Anti-CD45 Antibody Business (2021-2026)
7.9.5 GeneTex Recent Development
7.10 NSJ Bioreagents
7.10.1 NSJ Bioreagents Company Details
7.10.2 NSJ Bioreagents Business Overview
7.10.3 NSJ Bioreagents Anti-CD45 Antibody Introduction
7.10.4 NSJ Bioreagents Revenue in Anti-CD45 Antibody Business (2021-2026)
7.10.5 NSJ Bioreagents Recent Development
7.11 Abcam
7.11.1 Abcam Company Details
7.11.2 Abcam Business Overview
7.11.3 Abcam Anti-CD45 Antibody Introduction
7.11.4 Abcam Revenue in Anti-CD45 Antibody Business (2021-2026)
7.11.5 Abcam Recent Development
7.12 Bioss
7.12.1 Bioss Company Details
7.12.2 Bioss Business Overview
7.12.3 Bioss Anti-CD45 Antibody Introduction
7.12.4 Bioss Revenue in Anti-CD45 Antibody Business (2021-2026)
7.12.5 Bioss Recent Development
7.13 CUSABIO Technology
7.13.1 CUSABIO Technology Company Details
7.13.2 CUSABIO Technology Business Overview
7.13.3 CUSABIO Technology Anti-CD45 Antibody Introduction
7.13.4 CUSABIO Technology Revenue in Anti-CD45 Antibody Business (2021-2026)
7.13.5 CUSABIO Technology Recent Development
7.14 LSBio
7.14.1 LSBio Company Details
7.14.2 LSBio Business Overview
7.14.3 LSBio Anti-CD45 Antibody Introduction
7.14.4 LSBio Revenue in Anti-CD45 Antibody Business (2021-2026)
7.14.5 LSBio Recent Development
7.15 StressMarq Biosciences
7.15.1 StressMarq Biosciences Company Details
7.15.2 StressMarq Biosciences Business Overview
7.15.3 StressMarq Biosciences Anti-CD45 Antibody Introduction
7.15.4 StressMarq Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026)
7.15.5 StressMarq Biosciences Recent Development
7.16 BioLegend
7.16.1 BioLegend Company Details
7.16.2 BioLegend Business Overview
7.16.3 BioLegend Anti-CD45 Antibody Introduction
7.16.4 BioLegend Revenue in Anti-CD45 Antibody Business (2021-2026)
7.16.5 BioLegend Recent Development
7.17 Cell Signaling Technology
7.17.1 Cell Signaling Technology Company Details
7.17.2 Cell Signaling Technology Business Overview
7.17.3 Cell Signaling Technology Anti-CD45 Antibody Introduction
7.17.4 Cell Signaling Technology Revenue in Anti-CD45 Antibody Business (2021-2026)
7.17.5 Cell Signaling Technology Recent Development
7.18 HUABIO
7.18.1 HUABIO Company Details
7.18.2 HUABIO Business Overview
7.18.3 HUABIO Anti-CD45 Antibody Introduction
7.18.4 HUABIO Revenue in Anti-CD45 Antibody Business (2021-2026)
7.18.5 HUABIO Recent Development
7.19 RayBiotech
7.19.1 RayBiotech Company Details
7.19.2 RayBiotech Business Overview
7.19.3 RayBiotech Anti-CD45 Antibody Introduction
7.19.4 RayBiotech Revenue in Anti-CD45 Antibody Business (2021-2026)
7.19.5 RayBiotech Recent Development
7.20 Elabscience Bionovation
7.20.1 Elabscience Bionovation Company Details
7.20.2 Elabscience Bionovation Business Overview
7.20.3 Elabscience Bionovation Anti-CD45 Antibody Introduction
7.20.4 Elabscience Bionovation Revenue in Anti-CD45 Antibody Business (2021-2026)
7.20.5 Elabscience Bionovation Recent Development
7.21 G Biosciences
7.21.1 G Biosciences Company Details
7.21.2 G Biosciences Business Overview
7.21.3 G Biosciences Anti-CD45 Antibody Introduction
7.21.4 G Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026)
7.21.5 G Biosciences Recent Development
7.22 Miltenyi Biotec
7.22.1 Miltenyi Biotec Company Details
7.22.2 Miltenyi Biotec Business Overview
7.22.3 Miltenyi Biotec Anti-CD45 Antibody Introduction
7.22.4 Miltenyi Biotec Revenue in Anti-CD45 Antibody Business (2021-2026)
7.22.5 Miltenyi Biotec Recent Development
7.23 Beijing Solarbio Science & Technology
7.23.1 Beijing Solarbio Science & Technology Company Details
7.23.2 Beijing Solarbio Science & Technology Business Overview
7.23.3 Beijing Solarbio Science & Technology Anti-CD45 Antibody Introduction
7.23.4 Beijing Solarbio Science & Technology Revenue in Anti-CD45 Antibody Business (2021-2026)
7.23.5 Beijing Solarbio Science & Technology Recent Development
7.24 OriGene Technologies
7.24.1 OriGene Technologies Company Details
7.24.2 OriGene Technologies Business Overview
7.24.3 OriGene Technologies Anti-CD45 Antibody Introduction
7.24.4 OriGene Technologies Revenue in Anti-CD45 Antibody Business (2021-2026)
7.24.5 OriGene Technologies Recent Development
7.25 American Research Products
7.25.1 American Research Products Company Details
7.25.2 American Research Products Business Overview
7.25.3 American Research Products Anti-CD45 Antibody Introduction
7.25.4 American Research Products Revenue in Anti-CD45 Antibody Business (2021-2026)
7.25.5 American Research Products Recent Development
7.26 SouthernBiotech
7.26.1 SouthernBiotech Company Details
7.26.2 SouthernBiotech Business Overview
7.26.3 SouthernBiotech Anti-CD45 Antibody Introduction
7.26.4 SouthernBiotech Revenue in Anti-CD45 Antibody Business (2021-2026)
7.26.5 SouthernBiotech Recent Development
7.27 Tonbo Biosciences
7.27.1 Tonbo Biosciences Company Details
7.27.2 Tonbo Biosciences Business Overview
7.27.3 Tonbo Biosciences Anti-CD45 Antibody Introduction
7.27.4 Tonbo Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026)
7.27.5 Tonbo Biosciences Recent Development
7.28 Absolute Antibody
7.28.1 Absolute Antibody Company Details
7.28.2 Absolute Antibody Business Overview
7.28.3 Absolute Antibody Anti-CD45 Antibody Introduction
7.28.4 Absolute Antibody Revenue in Anti-CD45 Antibody Business (2021-2026)
7.28.5 Absolute Antibody Recent Development
8 Anti-CD45 Antibody Market Dynamics
8.1 Anti-CD45 Antibody Industry Trends
8.2 Anti-CD45 Antibody Market Drivers
8.3 Anti-CD45 Antibody Market Challenges
8.4 Anti-CD45 Antibody Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Anti-CD45 Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Anti-CD45 Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Anti-CD45 Antibody Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Anti-CD45 Antibody Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Anti-CD45 Antibody Revenue Share by Region (2021-2026)
Table 6. Global Anti-CD45 Antibody Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Anti-CD45 Antibody Revenue Share Forecast by Region (2027-2032)
Table 8. Global Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Anti-CD45 Antibody Market Share by Revenue, by Type (2021-2026)
Table 10. Global Anti-CD45 Antibody Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Anti-CD45 Antibody Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Anti-CD45 Antibody Market Share by Revenue, by Application (2021-2026)
Table 15. Global Anti-CD45 Antibody Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Anti-CD45 Antibody Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Anti-CD45 Antibody Applications
Table 18. Global Anti-CD45 Antibody Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Anti-CD45 Antibody Market Share by Players (2021-2026)
Table 20. Global Top Anti-CD45 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD45 Antibody as of 2025)
Table 21. Ranking of Global Top Anti-CD45 Antibody Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Anti-CD45 Antibody Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Anti-CD45 Antibody, Headquarters and Area Served
Table 24. Global Key Players of Anti-CD45 Antibody, Product and Application
Table 25. Global Key Players of Anti-CD45 Antibody, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Anti-CD45 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Anti-CD45 Antibody Market Share by Revenue, by Company (2021-2026)
Table 29. North America Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Anti-CD45 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Anti-CD45 Antibody Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Anti-CD45 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Anti-CD45 Antibody Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Anti-CD45 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Anti-CD45 Antibody Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Anti-CD45 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Anti-CD45 Antibody Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Anti-CD45 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Anti-CD45 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 47. BosterBio Company Details
Table 48. BosterBio Business Overview
Table 49. BosterBio Anti-CD45 Antibody Product
Table 50. BosterBio Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 51. BosterBio Recent Development
Table 52. Novus Biologicals Company Details
Table 53. Novus Biologicals Business Overview
Table 54. Novus Biologicals Anti-CD45 Antibody Product
Table 55. Novus Biologicals Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 56. Novus Biologicals Recent Development
Table 57. Bio-Rad Company Details
Table 58. Bio-Rad Business Overview
Table 59. Bio-Rad Anti-CD45 Antibody Product
Table 60. Bio-Rad Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 61. Bio-Rad Recent Development
Table 62. MyBioSource Company Details
Table 63. MyBioSource Business Overview
Table 64. MyBioSource Anti-CD45 Antibody Product
Table 65. MyBioSource Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 66. MyBioSource Recent Development
Table 67. Leica Biosystems Company Details
Table 68. Leica Biosystems Business Overview
Table 69. Leica Biosystems Anti-CD45 Antibody Product
Table 70. Leica Biosystems Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 71. Leica Biosystems Recent Development
Table 72. Biorbyt Company Details
Table 73. Biorbyt Business Overview
Table 74. Biorbyt Anti-CD45 Antibody Product
Table 75. Biorbyt Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 76. Biorbyt Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Anti-CD45 Antibody Product
Table 80. Thermo Fisher Scientific Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. R&D Systems Company Details
Table 83. R&D Systems Business Overview
Table 84. R&D Systems Anti-CD45 Antibody Product
Table 85. R&D Systems Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 86. R&D Systems Recent Development
Table 87. GeneTex Company Details
Table 88. GeneTex Business Overview
Table 89. GeneTex Anti-CD45 Antibody Product
Table 90. GeneTex Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 91. GeneTex Recent Development
Table 92. NSJ Bioreagents Company Details
Table 93. NSJ Bioreagents Business Overview
Table 94. NSJ Bioreagents Anti-CD45 Antibody Product
Table 95. NSJ Bioreagents Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 96. NSJ Bioreagents Recent Development
Table 97. Abcam Company Details
Table 98. Abcam Business Overview
Table 99. Abcam Anti-CD45 Antibody Product
Table 100. Abcam Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 101. Abcam Recent Development
Table 102. Bioss Company Details
Table 103. Bioss Business Overview
Table 104. Bioss Anti-CD45 Antibody Product
Table 105. Bioss Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 106. Bioss Recent Development
Table 107. CUSABIO Technology Company Details
Table 108. CUSABIO Technology Business Overview
Table 109. CUSABIO Technology Anti-CD45 Antibody Product
Table 110. CUSABIO Technology Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 111. CUSABIO Technology Recent Development
Table 112. LSBio Company Details
Table 113. LSBio Business Overview
Table 114. LSBio Anti-CD45 Antibody Product
Table 115. LSBio Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 116. LSBio Recent Development
Table 117. StressMarq Biosciences Company Details
Table 118. StressMarq Biosciences Business Overview
Table 119. StressMarq Biosciences Anti-CD45 Antibody Product
Table 120. StressMarq Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 121. StressMarq Biosciences Recent Development
Table 122. BioLegend Company Details
Table 123. BioLegend Business Overview
Table 124. BioLegend Anti-CD45 Antibody Product
Table 125. BioLegend Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 126. BioLegend Recent Development
Table 127. Cell Signaling Technology Company Details
Table 128. Cell Signaling Technology Business Overview
Table 129. Cell Signaling Technology Anti-CD45 Antibody Product
Table 130. Cell Signaling Technology Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 131. Cell Signaling Technology Recent Development
Table 132. HUABIO Company Details
Table 133. HUABIO Business Overview
Table 134. HUABIO Anti-CD45 Antibody Product
Table 135. HUABIO Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 136. HUABIO Recent Development
Table 137. RayBiotech Company Details
Table 138. RayBiotech Business Overview
Table 139. RayBiotech Anti-CD45 Antibody Product
Table 140. RayBiotech Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 141. RayBiotech Recent Development
Table 142. Elabscience Bionovation Company Details
Table 143. Elabscience Bionovation Business Overview
Table 144. Elabscience Bionovation Anti-CD45 Antibody Product
Table 145. Elabscience Bionovation Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 146. Elabscience Bionovation Recent Development
Table 147. G Biosciences Company Details
Table 148. G Biosciences Business Overview
Table 149. G Biosciences Anti-CD45 Antibody Product
Table 150. G Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 151. G Biosciences Recent Development
Table 152. Miltenyi Biotec Company Details
Table 153. Miltenyi Biotec Business Overview
Table 154. Miltenyi Biotec Anti-CD45 Antibody Product
Table 155. Miltenyi Biotec Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 156. Miltenyi Biotec Recent Development
Table 157. Beijing Solarbio Science & Technology Company Details
Table 158. Beijing Solarbio Science & Technology Business Overview
Table 159. Beijing Solarbio Science & Technology Anti-CD45 Antibody Product
Table 160. Beijing Solarbio Science & Technology Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 161. Beijing Solarbio Science & Technology Recent Development
Table 162. OriGene Technologies Company Details
Table 163. OriGene Technologies Business Overview
Table 164. OriGene Technologies Anti-CD45 Antibody Product
Table 165. OriGene Technologies Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 166. OriGene Technologies Recent Development
Table 167. American Research Products Company Details
Table 168. American Research Products Business Overview
Table 169. American Research Products Anti-CD45 Antibody Product
Table 170. American Research Products Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 171. American Research Products Recent Development
Table 172. SouthernBiotech Company Details
Table 173. SouthernBiotech Business Overview
Table 174. SouthernBiotech Anti-CD45 Antibody Product
Table 175. SouthernBiotech Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 176. SouthernBiotech Recent Development
Table 177. Tonbo Biosciences Company Details
Table 178. Tonbo Biosciences Business Overview
Table 179. Tonbo Biosciences Anti-CD45 Antibody Product
Table 180. Tonbo Biosciences Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 181. Tonbo Biosciences Recent Development
Table 182. Absolute Antibody Company Details
Table 183. Absolute Antibody Business Overview
Table 184. Absolute Antibody Anti-CD45 Antibody Product
Table 185. Absolute Antibody Revenue in Anti-CD45 Antibody Business (2021-2026) & (US$ Million)
Table 186. Absolute Antibody Recent Development
Table 187. Anti-CD45 Antibody Market Trends
Table 188. Anti-CD45 Antibody Market Drivers
Table 189. Anti-CD45 Antibody Market Challenges
Table 190. Anti-CD45 Antibody Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources


List of Figures
Figure 1. Anti-CD45 Antibody Product Picture
Figure 2. Global Anti-CD45 Antibody Market Share by Type: 2025 vs 2032
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global Anti-CD45 Antibody Market Share by Application: 2025 vs 2032
Figure 6. Biotechnology
Figure 7. Medical
Figure 8. University
Figure 9. Others
Figure 10. Anti-CD45 Antibody Report Years Considered
Figure 11. Global Anti-CD45 Antibody Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Anti-CD45 Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Anti-CD45 Antibody Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Anti-CD45 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Anti-CD45 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific Anti-CD45 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America Anti-CD45 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa Anti-CD45 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Anti-CD45 Antibody Market Share by Players in 2025
Figure 20. Global Top Anti-CD45 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD45 Antibody as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Anti-CD45 Antibody Revenue in 2025
Figure 22. North America Anti-CD45 Antibody Market Share by Type (2021-2026)
Figure 23. North America Anti-CD45 Antibody Market Share by Application (2021-2026)
Figure 24. Europe Anti-CD45 Antibody Market Share by Type (2021-2026)
Figure 25. Europe Anti-CD45 Antibody Market Share by Application (2021-2026)
Figure 26. Asia-Pacific Anti-CD45 Antibody Market Share by Type (2021-2026)
Figure 27. Asia-Pacific Anti-CD45 Antibody Market Share by Application (2021-2026)
Figure 28. Latin America Anti-CD45 Antibody Market Share by Type (2021-2026)
Figure 29. Latin America Anti-CD45 Antibody Market Share by Application (2021-2026)
Figure 30. Middle East & Africa Anti-CD45 Antibody Market Share by Type (2021-2026)
Figure 31. Middle East & Africa Anti-CD45 Antibody Market Share by Application (2021-2026)
Figure 32. BosterBio Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 33. Novus Biologicals Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 34. Bio-Rad Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 35. MyBioSource Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 36. Leica Biosystems Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 37. Biorbyt Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 39. R&D Systems Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 40. GeneTex Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 41. NSJ Bioreagents Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 42. Abcam Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 43. Bioss Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 44. CUSABIO Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 45. LSBio Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 46. StressMarq Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 47. BioLegend Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 48. Cell Signaling Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 49. HUABIO Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 50. RayBiotech Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 51. Elabscience Bionovation Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 52. G Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 53. Miltenyi Biotec Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 54. Beijing Solarbio Science & Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 55. OriGene Technologies Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 56. American Research Products Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 57. SouthernBiotech Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 58. Tonbo Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 59. Absolute Antibody Revenue Growth Rate in Anti-CD45 Antibody Business (2021-2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed